Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate

Published:2001-08 Issue: Volume:28 Page:8-15
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

BERRY W

Publisher

Elsevier BV

Subject

Oncology,Hematology

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study;British Journal of Clinical Pharmacology;2019-03-21

2. Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond;Endocrine-Related Cancer;2019-01

3. Can RECIST response predict success in phase 3 trials in men with metastatic castration-resistant prostate cancer?;Prostate Cancer and Prostatic Diseases;2018-06-01

4. Prostate Cancer;The American Cancer Society's Oncology in Practice;2018-02-16

5. Chemotherapy and Androgen Receptor-Directed Treatment of Castration Resistant Metastatic Prostate Cancer;Management of Prostate Cancer;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP